From Herbs to pills to genetic tools: The rise of cardiovascular pharmacotherapy: Professor Thomas Luscher




Join Professor Thomas Lüscher, President of the European Society of Cardiology and Director of Research, Education and Development at Royal Brompton & Harefield Hospitals, for an exploration of cardiovascular medicine's evolution. Drawing from his extensive experience as editor of the ESC Textbook of Cardiovascular Medicine, Professor Lüscher will guide us through the fascinating journey from traditional herbal remedies to modern genetic tools in cardiovascular treatment.

 

Time Session
11:00 - 11:05 Welcome and Introductions
Professor Pasquale Maffia
11:05 - 11:40 From Herbs to Pills to Genetic Tools: The Rise of Cardiovascular Pharmacotherapy
Professor Thomas Lüscher
11:40 - 11:45 Q&A and Closing Remarks
11:45 Close

Professor Thomas Lüscher 

Photo

Speaker: Professor Thomas Lüscher, ESC Textbook of Cardiovascular Medicine

Biography: Professor Lüscher (www.tomluescher.ch) studied medicine at the University of Zurich and obtained board certification in internal medicine and cardiology in Switzerland and is GMC certified in the U.K..

He trained at the Mayo Clinic in Rochester, MN, USA in cardiovascular physiology and cardiology and was Professor of Pharmacotherapy and Director of Clinical Pharmacology at the University Hospitals Basel, then Professor and Vice-Chairman of Cardiology at the University Hospital Bern and later Professor and Chairman of Cardiology and Director of the University Heart Center at the University Hospital Zurich, Switzerland. Since 2017, he is Director of Research, Education & Development and consultant cardiologist at the Royal Brompton & Harefield Hospitals and professor of cardiology at King’s College in London, U.K.. Since October 2023 he is also Co-Director of the Cardiovascular Academic Group of King’s College. He further holds a parttime commitment as Chairman of the Center for Molecular Cardiology at the University of Zurich (see www.cmc.uzh.ch).
Professor Lüscher has been mentoring numerous physicians and scientists from around the world with many holding chairs or directorships at universities and major hospitals in Switzerland, Europe, Asia and North America.

His research is translational and focuses at the basic level on endothelium-derived mediators and their alteration with aging, atherosclerosis, lipids and inflammation as well as at the clinical level on coronary artery disease, acute coronary syndromes and heart failure. He is among the 0.1% most cited scientists with a h-index of 151 (Scopus).

He is an editor of the ESC Textbook of Cardiovascular Medicine (Oxford University Press 2019) and the Module Innere Medizin (Springer Verlag, Heidelberg, FRG) and of the Manual of Cardiovascular Medicine (Oxford University Press 2022). He lectures worldwide and is also active on social media (https://twitter.com/TomLuscher) and has his own Youtube channel (https://www.youtube.com/c/InsideCardiology). He was editor-in-chief of the European Heart Journal 2009-2020 (increase in IF from 8.9 to 29.9) and continues as senior editor. He is president of the European Society of
Cardiology 2024 - 2026.


Professor Pasquale Maffia 

Photo

Speaker: Professor Pasquale Maffia, University of Glasgow

Biography: I am currently a Professor of Cardiovascular Immunology at the University of Glasgow (UK) within the School of Infection & Immunity. Additionally, I serve as the School’s International Lead and co-lead of the ARUA/Guild Africa-Europe CoRE in Non-Communicable Diseases & Multimorbidity.

I am an elected fellow of the Royal Society of Biology, the British Pharmacological Society, and the European Society of Cardiology.

I am the Vice-President and Chair of the Engagement Committee for the British Pharmacological Society (BPS), Chair of the Immunopharmacology Committee for the International Union of Basic and Clinical Pharmacology (IUPHAR), and Chair of the Translational Research Medical Review Panel for Heart Research UK (HRUK). Additionally, I am a Nucleus Member of the European Society of Cardiology (ESC) Working Group on Atherosclerosis & Vascular Biology and serve on the Executive Committee of the British Atherosclerosis Society (BAS). I am also part of the Fellowship Committee of the British Heart Foundation (BHF) and the Immunotherapy Committee of the International Union of Immunological Societies (IUIS).

I am the Deputy Editor of Cardiovascular Research, Associate Editor of Pharmacological Research, and Editor-in-Chief of the Human Health Section of Frontiers for Young Minds. Additionally, I serve on the editorial boards of several journals, including Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) and Scientific Reports.

I have a strong interest in the role of the immune response in cardiovascular diseases. My research encompasses both basic and clinical studies, with a focus on understanding and targeting immune and inflammatory mechanisms involved in the pathophysiology of atherosclerosis, hypertension, and heart failure. I have published over 130 scientific papers in peer-reviewed journals including Nature Genetics, Nature Reviews Immunology, Nature Reviews Cardiology, Lancet Global Health, Immunity, European Heart Journal, Circulation, and Circulation Research.

Tickets


In-Person Ticket Member Ticket Free
In-Person Ticket Non-Member Ticket Free
From
12 December 2024
To
12 December 2024
Time
11:00 AM to 11:45 AM
Venue
Main Auditorium, Harrogate Convention Centre, Kings Road, Harrogate




Connect with us:

© 2021 British Pharmacological Society, The Schild Plot, 16 Angel Gate, City Road, London EC1V 2PT, United Kingdom

loading